Product Information
MIRTAZAPINE 30 MG ODT is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.4229 per EA under NDC 72578010484. Its NADAC has been published 184 times since Mar 29, 2023.
FDA first approved this application on Jun 1, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578010484
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA205798FDA Approved
6/1/2017
TE Code
AB
On Market Since
8/7/2022
Price Statistics
The NADAC for MIRTAZAPINE 30 MG ODT has been published 184 times since Mar 29, 2023, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4229 per EA |
|---|---|
| All-time high | $0.6154 (Jun 14, 2023) |
| All-time low | $0.2242 (Jul 17, 2024) |
| 52-week high | $0.5089 |
| 52-week low | $0.4022 |
| Median price | $0.4242 |
| Average price | $0.4328 |
| Largest weekly change | +69.0% (Aug 21, 2024) |
| Weeks tracked | 184 |
| Tracking since | Mar 29, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 30 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 30 MG ODT, manufactured by Viona Pharmaceuticals Inc., is $0.4229 per EA (NDC 72578010484), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 30 MG ODT changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 30 MG ODT has declined 26.1%. It has been tracked across 184 weekly CMS publications since Mar 29, 2023.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 30 MG ODT?
Since Mar 29, 2023, the NADAC for MIRTAZAPINE 30 MG ODT has ranged from a low of $0.2242 (Jul 17, 2024) to a high of $0.6154 (Jun 14, 2023), with a median of $0.4242 per EA.
Are there cheaper alternatives to MIRTAZAPINE 30 MG ODT?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRTAZAPINE 30 MG TABLET, is $0.0723 per EA — about 83% below MIRTAZAPINE 30 MG ODT.
Who manufactures MIRTAZAPINE 30 MG ODT?
MIRTAZAPINE 30 MG ODT (NDC 72578010484) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.